Dr. Glabman was a graduate scholar in the NIH Comparative Biomedical Scientist Training Program in partnership with Michigan State University and the National Cancer Institute, 2017-2023.
Prior to joining the program, Dr. Glabman received a master's degree in public health science from Tulane University in 2010 and her VMD in 2017 from the University of Pennsylvania. She completed her diagnostic pathology training and didactic graduate coursework at Michigan State University. She continued her research in the NCI's Molecular Imaging Branch under the mentorship of Dr. Peter Choyke and Dr. Noriko Sato. Her research centered on understanding the protumorigenic role of cancer-associated fibroblasts (CAFs) within the tumor microenvironment of mammary tumors using an MMTV-PyVT mouse model, and targeting CAFs using near-infrared photoimmunotherapy (NIR-PIT).
Members of her graduate committee included: Gisela Hussey DVM, PhD, Dalen Agnew DVM PhD DACVP, Margaret Petroff PhD, Noriko Sato MD PhD, Peter Choyke MD and Mark Simpson DVM PhD DACVP.
